Testing effectiveness (Phase 2)Study completedNCT02487095
What this trial is testing
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
Who this might be right for
Carcinoma, Non-Small -Cell LungOvarian NeoplasmsSmall Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 62